Andrew J. Read

Dr. Andrew J. Read


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2006 in Cell
Verified
Journal Article
Closed access
DBDiana M. Bautista
Diana M. Bautista
SJSven-Eric Jordt
Sven-Eric Jordt
TNTetsuro Nikai
Tetsuro Nikai
PTPamela R. Tsuruda
Pamela R. Tsuruda
ARAndrew J. Read
Andrew J. Read
DJDavid Julius
David Julius

16 August 2012 in Neurogastroenterology & Motility
Verified
Journal Article
Closed access
PDF file
YXY. Xiao
Y. Xiao
ARAndrew J. Read
Andrew J. Read
FNF. Nicodème
F. Nicodème
SRS. Roman
S. Roman
PKP. J. Kahrilas
P. J. Kahrilas
JPJ. E. Pandolfino
J. E. Pandolfino

13 April 2022 in Gut
Verified
Journal Article
Open access
PDF file
AWAkbar K Waljee
Akbar K Waljee
EWEileen M Weinheimer-Haus
Eileen M Weinheimer-Haus
AAAmina Abubakar
Amina Abubakar
ANAnthony K Ngugi
Anthony K Ngugi
GSGeoffrey Siwo
Geoffrey Siwo
MSMansoor N Saleh
Mansoor N Saleh

1 September 2005 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
BYBogdan Yatsula
Bogdan Yatsula
SLSharon Lin
Sharon Lin
ARAndrew J. Read
Andrew J. Read
APAmanda Poholek
Amanda Poholek
KYKristin Yates
Kristin Yates
APArchibald S. Perkins
Archibald S. Perkins
The leukemia-associated protein EVI1 possesses seven zinc fingers within an N-terminal domain (amino acids 1–250) that binds to GACAAGATA. Single amino acid missense mutants of EVI1 were developed that failed to bind DNA either in vitro, as assessed by gel shift assay, or in vivo, as shown by transactivation studies. Specifically, mutation R205N lacks high affinity binding to the GACAAGATA motif. Putative EVI1 target genes were identified by using an EVI1-(1–250)-VP16 fusion protein that acts as a transcriptional activator with the binding specificity of EVI1. Sixteen genes induced in NIH 3T3 cells by wild type EVI1-VP16 but not by mutant forms were identified. Sequence analysis revealed evolutionarily conserved GACAAGATA-like motifs within 10 kb of their transcription start sites, and by chromatin immunoprecipitation in fibroblasts, we showed occupancy of many of these sites by EVI1-VP16. To assess whether native EVI1 binds to these sites in EVI1-transformed myeloid cells, we performed chromatin immunoprecipitation in 32Dcl3 and NFS58 cells, using anti-EVI1 antisera, and we showed that the majority of these sites is bound by wild type EVI1. These putative target genes include Gadd45g, Gata2, Zfpm2/Fog2, Skil (SnoN), Klf5 (BTEB2), Dcn, and Map3k14 (Nik). In this study we demonstrated for the first time that the N-terminal DNA binding domain of EVI1 has the capacity to bind to endogenous genes. We hypothesized that these genes play a critical role in EVI1-induced transformation.

22 February 2023 in Cancers
Verified
Journal Article
Open access
PDF file
ARAndrew J. Read
Andrew J. Read
WZWenjing Zhou
Wenjing Zhou
SSSameer D. Saini
Sameer D. Saini
JZJi Zhu
Ji Zhu
AWAkbar K. Waljee
Akbar K. Waljee
Background: Luminal gastrointestinal (GI) tract cancers, including esophageal, gastric, small bowel, colorectal, and anal cancers, are often diagnosed at late stages. These tumors can cause gradual GI bleeding, which may be unrecognized but detectable by subtle laboratory changes. Our aim was to develop models to predict luminal GI tract cancers using laboratory studies and patient characteristics using logistic regression and random forest machine learning methods. Methods: The study was a single-center, retrospective cohort at an academic medical center, with enrollment between 2004–2013 and with follow-up until 2018, who had at least two complete blood counts (CBCs). The primary outcome was the diagnosis of GI tract cancer. Prediction models were developed using multivariable single timepoint logistic regression, longitudinal logistic regression, and random forest machine learning. Results: The cohort included 148,158 individuals, with 1025 GI tract cancers. For 3-year prediction of GI tract cancers, the longitudinal random forest model performed the best, with an area under the receiver operator curve (AuROC) of 0.750 (95% CI 0.729–0.771) and Brier score of 0.116, compared to the longitudinal logistic regression model, with an AuROC of 0.735 (95% CI 0.713–0.757) and Brier score of 0.205. Conclusions: Prediction models incorporating longitudinal features of the CBC outperformed the single timepoint logistic regression models at 3-years, with a trend toward improved accuracy of prediction using a random forest machine learning model compared to a longitudinal logistic regression model.

1 October 2021 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
ARAndrew J. Read
Andrew J. Read
AWAkbar K. Waljee
Akbar K. Waljee
JSJeremy B. Sussman
Jeremy B. Sussman
HSHardeep Singh
Hardeep Singh
GCGrace Y. Chen
Grace Y. Chen
SSSameer D. Saini
Sameer D. Saini
Iron deficiency anemia (IDA) is a classic early diagnostic sign of gastrointestinal (GI) tract malignant neoplasm.1,2 Between 1% and 10% of adult patients with IDA may have undiagnosed GI tract cancer.3,4 Prompt and thorough evaluation of IDA is essential. However, retrospective studies have reported that delays in diagnostic evaluation of IDA are common5,6 and can lead to a delayed diagnosis of colorectal cancer.7,8 This problem is of increasing importance given the increasing incidence of colorectal cancer among younger patients outside the age range for which routine colorectal cancer screening is recommended, for whom IDA may be the first diagnostic sign of malignant neoplasm.9,10